Senator John Fetterman continues to fulfill Senate duties with recent legislative activity, including bipartisan bills and meetings through August 2026, supporting trader expectations that he will remain in office past December 31, 2026. Public statements reaffirm his intent to stay with Democrats absent an official party shift on Israel, while recent health incidents such as a November 2025 cardiac episode resulted in full recovery without extended absences. Staff turnover and isolated calls for resignation from critics have not produced formal challenges, vacancies, or confirmation processes that would alter his term ending in 2028. The 91.5% implied probability for “No” aligns with this continuity in the absence of qualifying developments.
Resumen experimental generado por IA con datos de Polymarket. Esto no es asesoramiento de trading y no influye en cómo se resuelve este mercado. · ActualizadoSí
8% probabilidad
NUEVO
NUEVO
31 dic 2026
Sí
8% probabilidad
NUEVO
NUEVO
31 dic 2026
This market will resolve to “Yes” if John Fetterman ceases to be U.S. Senator from Pennsylvania for any period of time between market creation and the specified date (ET). Otherwise, this market will resolve to “No”.
An announcement of John Fetterman's resignation/removal before this market's end date will immediately resolve this market to "Yes", regardless of when the announced resignation/removal goes into effect.
The resolution source for this market will be official information from John Fetterman and the U.S. government; however, a consensus of credible reporting may also be used.Senator John Fetterman continues to fulfill Senate duties with recent legislative activity, including bipartisan bills and meetings through August 2026, supporting trader expectations that he will remain in office past December 31, 2026. Public statements reaffirm his intent to stay with Democrats absent an official party shift on Israel, while recent health incidents such as a November 2025 cardiac episode resulted in full recovery without extended absences. Staff turnover and isolated calls for resignation from critics have not produced formal challenges, vacancies, or confirmation processes that would alter his term ending in 2028. The 91.5% implied probability for “No” aligns with this continuity in the absence of qualifying developments.
This market will resolve to “Yes” if John Fetterman ceases to be U.S. Senator from Pennsylvania for any period of time between market creation and the specified date (ET). Otherwise, this market will resolve to “No”.
An announcement of John Fetterman's resignation/removal before this market's end date will immediately resolve this market to "Yes", regardless of when the announced resignation/removal goes into effect.
The resolution source for this market will be official information from John Fetterman and the U.S. government; however, a consensus of credible reporting may also be used.
An announcement of John Fetterman's resignation/removal before this market's end date will immediately resolve this market to "Yes", regardless of when the announced resignation/removal goes into effect.
The resolution source for this market will be official information from John Fetterman and the U.S. government; however, a consensus of credible reporting may also be used.
Mercado abierto: Nov 14, 2025, 7:17 PM ET
Volumen
$1,296Fecha de finalización
31 dic 2026Mercado abierto
Nov 14, 2025, 7:17 PM ETResolver
0x65070BE91...This market will resolve to “Yes” if John Fetterman ceases to be U.S. Senator from Pennsylvania for any period of time between market creation and the specified date (ET). Otherwise, this market will resolve to “No”.
An announcement of John Fetterman's resignation/removal before this market's end date will immediately resolve this market to "Yes", regardless of when the announced resignation/removal goes into effect.
The resolution source for this market will be official information from John Fetterman and the U.S. government; however, a consensus of credible reporting may also be used.Senator John Fetterman continues to fulfill Senate duties with recent legislative activity, including bipartisan bills and meetings through August 2026, supporting trader expectations that he will remain in office past December 31, 2026. Public statements reaffirm his intent to stay with Democrats absent an official party shift on Israel, while recent health incidents such as a November 2025 cardiac episode resulted in full recovery without extended absences. Staff turnover and isolated calls for resignation from critics have not produced formal challenges, vacancies, or confirmation processes that would alter his term ending in 2028. The 91.5% implied probability for “No” aligns with this continuity in the absence of qualifying developments.
This market will resolve to “Yes” if John Fetterman ceases to be U.S. Senator from Pennsylvania for any period of time between market creation and the specified date (ET). Otherwise, this market will resolve to “No”.
An announcement of John Fetterman's resignation/removal before this market's end date will immediately resolve this market to "Yes", regardless of when the announced resignation/removal goes into effect.
The resolution source for this market will be official information from John Fetterman and the U.S. government; however, a consensus of credible reporting may also be used.
An announcement of John Fetterman's resignation/removal before this market's end date will immediately resolve this market to "Yes", regardless of when the announced resignation/removal goes into effect.
The resolution source for this market will be official information from John Fetterman and the U.S. government; however, a consensus of credible reporting may also be used.
Volumen
$1,296Fecha de finalización
31 dic 2026Mercado abierto
Nov 14, 2025, 7:17 PM ETResolver
0x65070BE91...Senator John Fetterman continues to fulfill Senate duties with recent legislative activity, including bipartisan bills and meetings through August 2026, supporting trader expectations that he will remain in office past December 31, 2026. Public statements reaffirm his intent to stay with Democrats absent an official party shift on Israel, while recent health incidents such as a November 2025 cardiac episode resulted in full recovery without extended absences. Staff turnover and isolated calls for resignation from critics have not produced formal challenges, vacancies, or confirmation processes that would alter his term ending in 2028. The 91.5% implied probability for “No” aligns with this continuity in the absence of qualifying developments.
Resumen experimental generado por IA con datos de Polymarket. Esto no es asesoramiento de trading y no influye en cómo se resuelve este mercado. · Actualizado
Cuidado con los enlaces externos.
Cuidado con los enlaces externos.
Preguntas frecuentes